Argentine Tennis Association
Buenos Aires, Argentina
NCT Number: NCT00792376
The purpose of this study is to evaluate etoricoxib efficacy in pain control, leg stiffness and functional recovery of patients suffering acute Achilles tendinopathy.
It is hypothesized that etoricoxib (120mg orally/day/7 days) efficacy is not inferior to diclofenac (150mg orally /day/7 days) for pain control in subjects suffering acute Achilles tendinopathy.
Looking for future studies?
Notify Me18 year–50 year
Male
Interventional
Phase 4
Buenos Aires, Argentina
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
etoricoxib (ETO) group (n=28) treated with etoricoxib 120 mg/day orally for 7 days
diclofenac (DIC) group (n=28) received diclofenac 150 mg/day/7 days orally.
Time frame: 1 week
Time frame: 1 week
Argentine Tennis Association
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06803056
Achilles Tendinopathy, Controls
Iowa City, Iowa, United States
View Trial DetailsNCT06134856
Achilles Tendinopathy, Achilles Tendon Pain
Suwanee, Georgia, United States
View Trial DetailsNCT06080334
Achilles Tendinopathy, Muscular Diseases
Ávila, Spain
View Trial DetailsNCT04816188
Achilles Tendinopathy, Apophysitis; Calcaneus
Newark, Delaware, United States
View Trial Details